|
|
Article: RENAGEL SIGNIFICANTLY SLOWS PROGRESSION OF CARDIAC CALCIFICATION; NEW STUDY RESULTS ANNOUNCED.
- Article from:
- PR Newswire
- Article date:
- June 26, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PR Newswire, London, June 26. This press release is transmitted on behalf of Genzyme
Vienna, Austria -
Kidney dialysis patients experienced no significant progression of cardiac calcification when using Renagel(R) (sevelamer hydrochloride), a calcium-free, aluminium-free medication designed to control phosphorus in their bloodstream, according to study results released today. Conversely, patients using calcium-based phosphate binders continued to develop cardiac calcification, a form of cardiovascular disease in which calcium deposits form within the blood vessels around the heart.
The study, which was presented at the European Dialysis and ...